1. Home
  2. NUVL vs SKM Comparison

NUVL vs SKM Comparison

Compare NUVL & SKM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$105.83

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo SK Telecom Co. Ltd.

SKM

SK Telecom Co. Ltd.

HOLD

Current Price

$23.22

Market Cap

7.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
SKM
Founded
2017
1984
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.9B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
NUVL
SKM
Price
$105.83
$23.22
Analyst Decision
Strong Buy
Hold
Analyst Count
15
1
Target Price
$135.00
N/A
AVG Volume (30 Days)
548.0K
734.1K
Earning Date
02-26-2026
02-11-2026
Dividend Yield
N/A
4.07%
EPS Growth
N/A
N/A
EPS
N/A
1.89
Revenue
N/A
$12,327,044,068.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.05
P/E Ratio
N/A
$22.29
Revenue Growth
N/A
N/A
52 Week Low
$55.54
$19.66
52 Week High
$112.88
$23.80

Technical Indicators

Market Signals
Indicator
NUVL
SKM
Relative Strength Index (RSI) 54.70 82.18
Support Level $97.43 $20.19
Resistance Level $108.65 $21.13
Average True Range (ATR) 4.95 0.27
MACD 0.48 0.21
Stochastic Oscillator 82.96 95.86

Price Performance

Historical Comparison
NUVL
SKM

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About SKM SK Telecom Co. Ltd.

SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.

Share on Social Networks: